Home » Topics » Science » New compound

New compound
RSS

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

No Comments

Samjin characterizes novel antitumor agent

May 14, 1997

No Comments

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

No Comments

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

No Comments

Lilly synthesizes antifolates that potently inhibit human DHFR

May 14, 1997

No Comments

Menarini prepares new NNRTIs with potent anti-HIV activity

May 13, 1997

No Comments

Orally active FdUrd derivative prepared at Taiho

May 13, 1997

No Comments

Pfizer and Oncogene characterize EGF receptor TK inhibitor

May 13, 1997

No Comments

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

No Comments

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

New compound
RSS

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

Samjin characterizes novel antitumor agent

Dual H1/NK1 antagonist for allergic rhinitis from HMR

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

Lilly synthesizes antifolates that potently inhibit human DHFR

Menarini prepares new NNRTIs with potent anti-HIV activity

Orally active FdUrd derivative prepared at Taiho

Pfizer and Oncogene characterize EGF receptor TK inhibitor

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

New compound RSS

New compound
RSS